Neuroone Medical Technologies (NMTC) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.98% |
| Dec 31, 2025 | 1.63% |
| Sep 30, 2025 | 17.77% |
| Jun 30, 2025 | 19.38% |
| Mar 31, 2025 | 26.25% |
| Dec 31, 2024 | 19.56% |
| Sep 30, 2024 | 58.75% |
| Jun 30, 2024 | 26.18% |
| Mar 31, 2024 | 15.94% |
| Dec 31, 2023 | 58.75% |
| Sep 30, 2023 | 105.92% |
| Jun 30, 2023 | 90.47% |
| Mar 31, 2023 | 96.85% |
| Dec 31, 2022 | 107.69% |
| Sep 30, 2022 | 116.79% |
| Dec 31, 2021 | 86.73% |
| Sep 30, 2021 | 350.53% |
| Jun 30, 2021 | 370.00% |
| Mar 31, 2021 | 479.98% |
| Dec 31, 2020 | 433.09% |
| Dec 31, 2019 | 564.64% |
| Jun 30, 2019 | 368.58% |
| Mar 31, 2019 | 452.53% |
| Dec 31, 2018 | 305.77% |
| Sep 30, 2018 | 224.49% |
| Jun 30, 2018 | 179.86% |
| Mar 31, 2018 | 116.43% |
| Dec 31, 2017 | 195.05% |
| Sep 30, 2017 | 182.63% |
| Dec 31, 2016 | 122.59% |
| Sep 30, 2016 | -2.72% |
| Jun 30, 2016 | 71.89% |
| Dec 31, 2015 | -27.43% |